Found: 7
Select item for more details and to access through your institution.
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia.
- Published in:
- 2024
- By:
- Publication type:
- Letter
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12160-2
- By:
- Publication type:
- Article
UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 898, doi. 10.3390/cancers14040898
- By:
- Publication type:
- Article
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6148, doi. 10.3390/cancers13236148
- By:
- Publication type:
- Article
FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report.
- Published in:
- Cytometry. Part A, 2024, v. 105, n. 1, p. 24, doi. 10.1002/cyto.a.24805
- By:
- Publication type:
- Article
Automated Flow Cytometric MRD Assessment in Childhood Acute B‐ Lymphoblastic Leukemia Using Supervised Machine Learning.
- Published in:
- Cytometry. Part A, 2019, v. 95, n. 9, p. 966, doi. 10.1002/cyto.a.23852
- By:
- Publication type:
- Article